Insights

Pharmaceutical Industry Insights, Technical Articles and Expert Interviews

Stay informed with practical insights from across the pharmaceutical outsourcing landscape.

Our News & Insights section features technical articles, expert commentary and interviews with service providers from the Pharma Services Hub network. Content covers pharmaceutical development, manufacturing, quality, regulatory affairs, analytical sciences, outsourcing strategy and emerging industry trends.

Whether you are evaluating service providers, developing a new product or seeking specialist knowledge, these resources are designed to support informed decision-making and help you navigate complex development challenges and service provider selection.

Capsule dissolving in a clear liquid

Biopharmaceutics Assessment: Identifying the Correct Approach for In Vitro Studies

As part of our small molecule insights series we review the growing importance of biopharmaceutics assessment with Dr. Mark McAllister, Chief Scientific Officer of Biowaived (UK). Mark shares his perspectives on how to identify the correct approach, avoid common pitfalls, and leverage in vitro testing to accelerate successful outcomes in drug product design and clinical exposure/efficacy.
Read More Biopharmaceutics Assessment: Identifying the Correct Approach for In Vitro Studies.
Lab equipment

Contract Research Organisation Selection - Important Considerations

As part of our discovery and development series Dr Shailendra Singh CEO at Cellomatics Biosciences provides his insights into the important considerations which must be made when identifying and building partnerships with Contract Research Organisations.
Read More Contract Research Organisation Selection - Important Considerations.
image to capsules inside a larger capsule

Essential aspects to consider when transitioning a lead candidate from Drug Substance to Drug Product using enabling formulation strategies

As part of our small molecule insights interview series, we review the Essential aspects to consider when transitioning a lead candidate from drug substance (DS) to drug product (DP) using enabling formulation strategies.
Read More Essential aspects to consider when transitioning a lead candidate from Drug Substance to Drug Product using enabling formulation strategies.
digital display of capsule

Accelerating Molecules to Medicines: The importance of End to End CMC Service Provision

As part of our technical insights series, we asked Tara Hope (Director - Business Development, Drug Product at Pharmaron) what are the key factors to consider when selecting organisations to support end to end CMC services.
Read More Accelerating Molecules to Medicines: The importance of End to End CMC Service Provision.
Lab equipment

Why Drug Solubility Matters: Understanding Its Central Role in Bioavailability and Successful DS/DP Development

As part of our small technical insights series Terry Ernest and Jonathan Loughrey explain Why Drug Solubility Matters and why choosing the right development partner is critical for project success.
Read More Why Drug Solubility Matters: Understanding Its Central Role in Bioavailability and Successful DS/DP Development.
Lab technician

How to author a robust validation of an analytical method for regulatory submission

Linda Cutler, a consultant at Regulink provides a short guide on how manufacturing site methods would typically be formatted and summarised for regulatory submissions.
Read More How to author a robust validation of an analytical method for regulatory submission.
Lab technician typing on computer keyboard

Making Informed Decisions: A Guide to Selecting the Right Contract Research Organisation Partner

As part of our technical insights series, we asked the team at Resolian about the key factors to consider when selecting CRO organisations that can support both discovery and early phase non-clinical studies, alongside clinical and GMP studies
Read More Making Informed Decisions: A Guide to Selecting the Right Contract Research Organisation Partner.
Microscope in a laboratory

How to author a robust analytical method for regulatory submission

Linda Cutler, a consultant at Regulink provides a short guide on how manufacturing site methods would typically be formatted and summarised for regulatory submissions
Read More How to author a robust analytical method for regulatory submission.